(34.200.243.114)
Users online: 2580    [ij] [ij] [ij] 
Email id
 

Research Journal of Pharmacy and Technology
Year : 2018, Volume : 11, Issue : 10
First page : ( 4511) Last page : ( 4514)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.5958/0974-360X.2018.00825.9

In Silico approach for the Rational Design of Tankyrase I Inhibitors-A Case Study on Flavone based Anticancer Leads

Kamath Venkatesh1, Pai Aravinda2,*, Raj Rohith3

1Department of Pharmaceutical Biotechnology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India

2Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India

3Scientist I, Department of Bio Analytical, Ecron Acunova, Manipal, Karnataka, India

*Corresponding Author E-mail: pai.aravind@gmail.com.

Online published on 20 December, 2018.

Abstract

In the present study, a series flavones were selected form the literature. The selected compounds were docked at the active site of Tankyrase I utilizing extra precision docking protocol. The docking scores of the selected compounds were then compared with a standard reported in the literature. The compounds showed comparable binding affinity at the active site of Tankyrase I. The study also enabled us in identifying the possible substitution sites to enhance the activity as well as selectivity towards the enzyme Tankyrase I. This could help the researchers in identifying lead molecule for colorectal cancer.

Top

Keywords

Tankyrase I, docking, ADP ribose, PARP, Colon cancer.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
434,937,657 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.